Initiator Pharma's presentation at Erik Penser Bank discusses biotechnology advancements, while Professor Peter Schantz explores how nature influences human health through GIH research. 00:10:00
Torgeir has extensive experience from the financial industry in Norway. Prior to joining Initiator Pharma he worked as a financial analyst with several Scandinavian investment banks, including ABG Sundal Collier, Handelsbanken Markets, Norden Equity and has been involved in a number of early stage pharmaceutical and biotechnology start ups. He holds a MSc from Norges Handelshøyskole (Norway) and a PhD from UC
